Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs6755030 | chr2:24318343 | C/T | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs6757526 | chr2:176198759 | A/G | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs67575381 | chr14:74575052 | A/T | 5.67E-7 | 175 | 25.4 | 27.43 | 7.4 | KM Plot |
PCPG | rs6757912 | chr2:242511547 | T/C | 3.49E-5 | 173 | 25.92 | 25.6 | 20.2 | KM Plot |
PCPG | rs6758284 | chr2:118550610 | C/T | 1.85E-5 | 176 | 24.85 | 30.63 | 11.65 | KM Plot |
PCPG | rs6758789 | chr2:242547375 | A/C | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs67596067 | chr17:50333733 | G/A | 0.00028 | 170 | 26.12 | 28.38 | 16.33 | KM Plot |
PCPG | rs67602711 | chr14:74400175 | T/G | 1.03E-5 | 177 | 25.4 | 28.38 | 10.43 | KM Plot |
PCPG | rs67678658 | chr21:38447606 | C/T | 5.33E-6 | 176 | 25 | 25.87 | 3.7 | KM Plot |
PCPG | rs67745756 | chr2:241539683 | T/C | 3.78E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs67771048 | chr17:2094807 | G/A | 0.000381 | 176 | 25.87 | 18 | 25.62 | KM Plot |
PCPG | rs6780379 | chr3:80560525 | A/G | 0.000294 | 178 | 19.87 | 23.43 | 27.95 | KM Plot |
PCPG | rs67816129 | chr8:135496810 | A/T | 0.000111 | 177 | 25.53 | 25.17 | 21.35 | KM Plot |
PCPG | rs67816797 | chr16:1757001 | T/C | 0 | 176 | 25.53 | 18.75 | 2.93 | KM Plot |
PCPG | rs6789243 | chr3:80581093 | C/T | 6.99E-5 | 176 | 19.53 | 24.53 | 27.2 | KM Plot |